Blog

Moderate Psoriasis: The New Frontier For Systemic Therapies UNVEIL trial shows apremilast hits the mark in this population. mdedge.com Topical Tapinarof Heads for Phase 3 in Atopic Dermatitis and Psoriasis…

Interleukin-23 inhibition for psoriasis shows ‘wow’ factor Most patients with moderate to severe plaque psoriasis on either guselkumab or tildrakizumab have at least PASI 90 sustained response at 2… mdedge.com…

Extended data support ixekizumab for plaque psoriasis An open-label, 4-year extension study of ixekizumab yields promising results. mdedge.com Ixekizumab beats ustekinumab for fingernail psoriasis, hands down GENEVA – Clear nails…

Liver Disease Increased in Psoriasis An observational case-control study has shown that psoriasis is associated with an increased… rheumnow.com MTX Doubles Hepatotoxicity Risk in Psoriasis Patients A study from the…

Potential Immunological Links Between Psoriasis and Cardiovascular Disease Pre-clinical and clinical research provide strong evidence that chronic, systemic inflammation plays a key role in development and progression of… frontiersin.org CBC…

PF Dietary Recommendations for Psoriatic Disease rheumnow.com Dietary Changes Can Lessen Severity of Psoriatic Disease The National Psoriasis Foundation Board strongly recommends a… medscape.com Diet and Psoriatic Disease: 5 Questions…

Psoriasis: A Primary Care Primer Most patients seen in primary care have mild to moderate plaque… rheumatologynetwork.com Clinically resolved psoriatic lesions contain psoriasis-specific IL-17–producing αβ T cell clones Address correspondence…

Autologous stem cell transplantation in systemic sclerosis: a systematic review Review; Authors: Lauren Host, Mandana Nikpour, Alicia Calderone, Paul Cannell, Janet Roddy clinexprheumatol.org Efficacy and safety of autologous haematopoietic stem…

Abituzumab may be potential treatment for scleroderma SAN DIEGO — Abituzumab has the potential to block TGF-beta-induced… healio.com Anti‐fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in…

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group ard.bmj.com Rituximab Shows Promise in Scleroderma medpagetoday.com A multicenter, open-label, comparative…